收稿日期: 2022-01-29
网络出版日期: 2022-05-09
基金资助
国家重点研发计划(2018YFC1312802);浦东新区卫生健康委员会联合攻关项目(PW2019D-11)
Baseline characteristics and lifestyle factors of single and co-morbidity of cardio-cerebrovascular diseases in Shanghai Community Elderly Cohort
Received date: 2022-01-29
Online published: 2022-05-09
Supported by
National Key R&D Program of China(2018YFC1312802);Joint Project of Health Committee of Pudong New Area(PW2019D-11)
目的·基于大规模前瞻性社区老年人群队列,探索心脑血管疾病单患、共患人群的流行病学和危险因素特征。方法·研究的对象来源于上海社区老年人群队列。该队列的基线调查始于2019年2月,结束于2019年8月,收集了包括队列成员的人口统计学信息、疾病史和家族史、生活方式、心理状况等信息。根据自我报告有无冠状动脉性心脏病(冠心病)和/或脑卒中将全部队列成员分为4组:冠心病单患组、脑卒中单患组、心脑血管疾病(冠心病+脑卒中)共患组以及对照组(无冠心病及脑卒中)。对这4组对象的基本信息、共患其他疾病情况、生活方式、心理状况、睡眠状态等进行分析比较。结果·17 948名符合入选标准的研究对象纳入队列研究,其中冠心病单患组2 050名、脑卒中单患组724名、心脑血管疾病共患组269名、对照组14 905名。4组人群平均年龄分别为(70.4±6.2)岁、(71.8±7.1)岁、(73.2±7.0)岁和(68.3±5.9)岁。心脑血管疾病共患组患者合并高血压(76.6%)、高脂血症(38.3%)、糖尿病(26.0%)等基础性疾病的比例最高,其次为脑卒中单患组(分别为74.2%、26.8%和25.8%)、冠心病单患组(分别为72.9%、21.1%和21.7%),而对照组最低(分别为54.6%、8.7%和15.4%)。心脑血管疾病共患组患者有抑郁症状(16.0%)、焦虑症状(13.1%)、久坐习惯(2.2%)、睡眠质量较差或很差(38.6%)的比例最高,其次是脑卒中单患组(分别为10.1%、6.6%、2.2%和27.2%)、冠心病单患组(分别为7.9%、4.8%、0.5%和27.0%)。心脑血管疾病共患组患者有规律运动习惯的比例(29.5%)最低,而对照组的规律运动比例(39.2%)最高。结论·冠心病、脑卒中患者尤其是冠心病+脑卒中共患者合并基础性疾病、具有不良生活习惯和心理疾患的比例较高。
蒋惠如 , 李峥 , 马卓然 , 魏霖 , 袁安彩 , 胡刘华 , 陈潇雨 , 郭韵悦 , 张薇 , 卜军 . 上海社区老年人群队列心脑血管疾病单患、共患基线情况及生活方式特征[J]. 上海交通大学学报(医学版), 2022 , 42(3) : 282 -289 . DOI: 10.3969/j.issn.1674-8115.2022.03.004
·To explore the epidemiology and risk factors of single and co-morbidity of cardio-cerebrovascular diseases based on a large-scale prospective cohort of elderly people in the community.
·The subjects of the study came from Shanghai Community Elderly Cohort. The baseline survey of this cohort began in February 2019 and ended in August 2019, collecting information including demographic information, diseases and family history, lifestyle and psychological status of cohort members. According to self-reported coronary heart disease and/or stroke, all cohort members were divided into four groups, which were single coronary heart disease group, single stroke group, cardio-cerebrovascular disease group (with both coronary heart disease and stroke), and control group (without coronary heart disease and stroke). Baseline information, disease history, lifestyle factors, psychological and sleep status among the four groups were analysed.
·A total of 17 948 eligible subjects participated in the cohort study, including 2 050 cohort members with single coronary heart disease, 724 cohort members with single stroke, 269 cohort members with cardio-cerebrovascular disease, and 14 905 cohort members without coronary heart disease and stroke. The average age of these four groups were (70.4±6.2) years, (71.8±7.1) years, (73.2±7.0) years and (68.3±5.9) years, respectively. The proportions of hypertension (76.6%), hyperlipidemia (38.3%) and diabetes (26.0%) were the highest in the cardio-cerebrovascular disease group, followed by the single stroke group (74.2%, 26.8% and 25.8%, respectively), and the single coronary heart disease group (72.9%, 21.1% and 21.7%, respectively), and the control group had the lowest proportion (54.6%, 8.7% and 15.4%, respectively). The proportions of depression symptoms (16.0%), anxiety symptoms (13.1%), sedentary habit (2.2%), and poor or fairly poor sleep (38.6%) in the cardio-cerebrovascular disease group were the highest, followed by the single stroke group (10.1%, 6.6%, 2.2% and 27.2%, respectively) and the single coronary heart disease group (7.9%, 4.8%, 0.5% and 27.0%, respectively). The proportion of regular exercise was the lowest in the cardio-cerebrovascular disease group (29.5%), while the proportion was the highest in the control group (39.2%).
·Patients with coronary heart disease or stroke, especially those with both coronary heart disease and stroke, have a high proportion of co-morbidity with primary diseases, unhealthy lifestyles and psychological disorders.
Key words: coronary heart disease; stroke; cohort; lifestyle
1 | VISSEREN F L J, MACH F, SMULDERS Y M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice[J]. Eur Heart J, 2021, 42(34): 3227-3337. |
2 | 国家统计局, 生态环境部. 中国环境统计年鉴(2020)[M]. 北京: 中国统计出版社, 2021. |
3 | 中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2020概要[J]. 中国循环杂志, 2021, 36(6): 521-545. |
4 | 上海市统计局. 上海统计年鉴[M]. 北京: 中国统计出版社, 2010. |
5 | 《中国循环杂志》编辑部. 缺血性脑卒中是冠心病等危症[J]. 中国循环杂志, 2013, 28(1): 76. |
6 | PENNELLS L, KAPTOGE S, WOOD A, et al. Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies[J]. Eur Heart J, 2019, 40(7): 621-631. |
7 | FUCHS F D, WHELTON P K. High blood pressure and cardiovascular disease[J]. Hypertension, 2020, 75(2): 285-292. |
8 | HERTTUA K, MARTIKAINEN P, BATTY G D, et al. Poor adherence to statin and antihypertensive therapies as risk factors for fatal stroke[J]. J Am Coll Cardiol, 2016, 67(13): 1507-1515. |
9 | RASHEED A, HABIB S, DAR M I, et al. Effect of risk factors like age, gender, hypertension, diabetes, smoking, dyslipidemia on coronary artery disease in Karachiites with angiographical data of local population: number, site, severity of coronary lesion[J]. Pak J Pharm Sci, 2014, 27(6 Spec No.): 2207-2212. |
10 | BARTNIK M, Rydén L, Ferrari R, et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe: the Euro Heart Survey on diabetes and the heart[J]. Eur Heart J, 2004, 25(21): 1880-1890. |
11 | MOSENZON O, ALGUWAIHES A, et al. CAPTURE: a multinational, cross-sectional study of cardiovascular disease prevalence in adults with type 2 diabetes across 13 countries[J]. Cardiovasc Diabetol, 2021, 20(1): 154. |
12 | COLLABORATION E R F, SARWAR N, GAO P, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies[J]. Lancet, 2010, 375(9733): 2215-2222. |
13 | COLLABORATION E R F, ANGELANTONIO E D, KAPTOGE S, et al. Association of cardiometabolic multimorbidity with mortality[J]. JAMA, 2015, 314(1): 52-60. |
14 | OH H G, RHEE E J, KIM T W, et al. Higher glycated hemoglobin level is associated with increased risk for ischemic stroke in non-diabetic Korean male adults[J]. Diabetes Metab J, 2011, 35(5): 551-557. |
15 | LIND M, IMBERG H, COLEMAN R L, et al. Historical HbA1c values may explain the type 2 diabetes legacy effect: ukpds 88[J]. Diabetes Care, 2021, 44(10): 2231-2237. |
16 | GUASCH-FERRé M, BABIO N, MARTíNEZ-GONZáLEZ M A, et al. Dietary fat intake and risk of cardiovascular disease and all-cause mortality in a population at high risk of cardiovascular disease[J]. Am J Clin Nutr, 2015, 102(6): 1563-1573. |
17 | 中华医学会心血管病学分会动脉粥样硬化与冠心病学组, 中华心血管病杂志编辑委员会. 超高危动脉粥样硬化性心血管疾病患者血脂管理中国专家共识[J]. 中华心血管病杂志, 2020, 48(4): 280-286. |
18 | HARSHFIELD E L, PENNELLS L, SCHWARTZ J E, et al. Association between depressive symptoms and incident cardiovascular diseases[J]. JAMA, 2020, 324(23): 2396-2405. |
19 | SONG H, FANG F, ARNBERG F K, et al. Stress related disorders and risk of cardiovascular disease: population based, sibling controlled cohort study[J]. BMJ, 2019, 365: l1255. |
20 | ROSENGREN A, HAWKEN S, OUNPUU S, et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11 119 cases and 13 648 controls from 52 countries (the INTERHEART study): case-control study[J]. Lancet, 2004, 364(9438): 953-962. |
21 | LI H B, ZHENG D Q, LI Z W, et al. Association of depressive symptoms with incident cardiovascular diseases in middle-aged and older Chinese adults[J]. JAMA Netw Open, 2019, 2(12): e1916591. |
22 | CARNEY R M, FREEDLAND K E. Depression and coronary heart disease[J]. Nat Rev Cardiol, 2017, 14(3): 145-155. |
23 | VACCARINO V, BADIMON L, BREMNER J D, et al. Depression and coronary heart disease: 2018 position paper of the ESC working group on coronary pathophysiology and microcirculation[J]. Eur Heart J, 2020, 41(17): 1687-1696. |
24 | LANDAU W M, WILLEY J Z, ELKIND M S V. Physical activity and risk of ischemic stroke in the Northern Manhattan study[J]. Neurology, 2010, 75(1): 94. |
25 | CHOMISTEK A K, COOK N R, RIMM E B, et al. Physical activity and incident cardiovascular disease in women: is the relation modified by level of global cardiovascular risk?[J]. J Am Heart Assoc, 2018, 7(12): e008234. |
26 | TIKKANEN E, GUSTAFSSON S, INGELSSON E. Associations of fitness, physical activity, strength, and genetic risk with cardiovascular disease: longitudinal analyses in the UK biobank study[J]. Circulation, 2018, 137(24): 2583-2591. |
27 | ALVES A J, VIANA J L, CAVALCANTE S L, et al. Physical activity in primary and secondary prevention of cardiovascular disease: overview updated[J]. World J Cardiol, 2016, 8(10): 575-583. |
28 | KATZMARZYK P T, CHURCH T S, CRAIG C L, et al. Sitting time and mortality from all causes, cardiovascular disease, and cancer[J]. Med Sci Sports Exerc, 2009, 41(5): 998-1005. |
29 | MATTHEWS C E, GEORGE S M, MOORE S C, et al. Amount of time spent in sedentary behaviors and cause-specific mortality in US adults[J]. Am J Clin Nutr, 2012, 95(2): 437-445. |
30 | HELD C, IQBAL R, LEAR S A, et al. Physical activity levels, ownership of goods promoting sedentary behaviour and risk of myocardial infarction: results of the INTERHEART study[J]. Eur Heart J, 2012, 33(4): 452-466. |
31 | SALTIN B, BLOMQVIST G, MITCHELL J H, et al. Response to exercise after bed rest and after training[J]. Circulation, 1968, 38(5 Suppl): VII1-VII78. |
32 | LIPMAN R L, RASKIN P, LOVE T, et al. Glucose intolerance during decreased physical activity in man[J]. Diabetes, 1972, 21(2): 101-107. |
33 | BEY L, HAMILTON M T. Suppression of skeletal muscle lipoprotein lipase activity during physical inactivity: a molecular reason to maintain daily low-intensity activity[J]. J Physiol, 2003, 551(Pt 2): 673-682. |
34 | SABANAYAGAM C, SHANKAR A. Sleep duration and cardiovascular disease: results from the National Health Interview Survey[J]. Sleep, 2010, 33(8): 1037-1042. |
35 | AMAGAI Y, ISHIKAWA S, GOTOH T, et al. Sleep duration and incidence of cardiovascular events in a Japanese population: the Jichi Medical School cohort study[J]. J Epidemiol, 2010, 20(2): 106-110. |
36 | GANGWISCH J E. A review of evidence for the link between sleep duration and hypertension[J]. Am J Hypertens, 2014, 27(10): 1235-1242. |
/
〈 |
|
〉 |